DekaBank Deutsche Girozentrale’s Iovance Biotherapeutics IOVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$170K	Hold	100,000	–	–	﹤0.01%	1157
2025 Q1	$344K	Hold	100,000	–	–	﹤0.01%	1028
2024 Q4	$727K	Hold	100,000	–	–	﹤0.01%	935
2024 Q3	$956K	Hold	100,000	–	–	﹤0.01%	896
2024 Q2	$797K	Hold	100,000	–	–	﹤0.01%	924
2024 Q1	$1.4M	Hold	100,000	–	–	﹤0.01%	815
2023 Q4	$867K	Hold	100,000	–	–	﹤0.01%	926
2023 Q3	$454K	Hold	100,000	–	–	﹤0.01%	1035
2023 Q2	$703K	Hold	100,000	–	–	﹤0.01%	952
2023 Q1	$610K	Hold	100,000	–	–	﹤0.01%	973
2022 Q4	$629K	Hold	100,000	–	–	﹤0.01%	985
2022 Q3	$942K	Sell	100,000 -23,900	-19%	-$225K	﹤0.01%	887
2022 Q2	$1.33M	Hold	123,900	–	–	﹤0.01%	812
2022 Q1	$2.07M	Buy	123,900 +11,300	+10%	+$189K	0.01%	742
2021 Q4	$2.17M	Sell	112,600 -15,000	-12%	-$289K	0.01%	750
2021 Q3	$3.06M	Hold	127,600	–	–	0.01%	639
2021 Q2	$3.34M	Buy	127,600 +64,000	+101%	+$1.68M	0.01%	620
2021 Q1	$1.88M	Hold	63,600	–	–	0.01%	711
2020 Q4	$3.05M	Buy	63,600 +35,800	+129%	+$1.72M	0.01%	562
2020 Q3	$894K	Buy	+27,800	New	+$894K	﹤0.01%	791
2019 Q3	–	Sell	-109,000	Closed	-$2.46M	–	1057
2019 Q2	$2.46M	Buy	109,000 +19,000	+21%	+$429K	0.01%	573
2019 Q1	$1.59M	Buy	90,000 +57,500	+177%	+$1.02M	0.01%	659
2018 Q4	$288K	Sell	32,500 -57,500	-64%	-$510K	﹤0.01%	916
2018 Q3	$1.59M	Sell	90,000 -2,400	-3%	-$42.4K	0.01%	671
2018 Q2	$1.2M	Buy	92,400 +50,000	+118%	+$648K	0.01%	708
2018 Q1	$700K	Buy	+42,400	New	+$700K	﹤0.01%	800
2016 Q2	–	Sell	-21,000	Closed	-$101K	–	1020
2016 Q1	$101K	Buy	+21,000	New	+$101K	﹤0.01%	955